34
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Tumor Mutation Burden as a Marker for Molecularly Matched Therapy: More Evidence Needed

ORCID Icon & ORCID Icon
Pages 1175-1178 | Received 09 Oct 2023, Accepted 01 Nov 2023, Published online: 15 Nov 2023
 

Supplementary data

To view the supplementary data that accompany this paper please visit the journal website at: www.tandfonline.com/doi/suppl/10.2217/epi-2023-0354

Author contributions

X-Y Meng, conceptualization, data curation, formal analysis, writing – original draft; Q-J Wu, data curation, writing – review editing.

Financial disclosure

X-Y Meng was supported by National Natural Science Foundation of China (82303057) and Natural Science Foundation of Hubei Province of China (2023AFB521). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Competing interests disclosure

The authors have no competing interests or relevant affiliations with any organization or entity with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

Writing disclosure

No writing assistance was utilized in the production of this manuscript.

Additional information

Funding

X-Y Meng was supported by National Natural Science Foundation of China (82303057) and Natural Science Foundation of Hubei Province of China (2023AFB521). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.